These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2877340)

  • 21. [Combined therapy of hyperlipoproteinemia. Colestipol and gemfibrozil in the treatment of heterozygous familial hypercholesterolemia].
    Ceska R; Sobra J; Toschnerová H; Traurig J
    Cas Lek Cesk; 1992 Mar; 131(6):183-5. PubMed ID: 1586935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb.
    Bertolini S; Elicio N; Daga A; Degl'Innocenti ML; Balestreri R; Fusi MG; Cotta Ramusino AM; Carozzi A
    Eur J Clin Pharmacol; 1988; 34(1):25-8. PubMed ID: 3282894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for familial hypercholesterolaemia.
    Lancet; 1981 Apr; 1(8226):925-6. PubMed ID: 6112333
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Leuven JA; Schouten JA; Stalenhoef AF
    Lancet; 1986 Oct; 2(8513):936-9. PubMed ID: 2877129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
    Vega GL; Grundy SM
    JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Colestipol in the treatment of heterozygous familial hypercholesterolemia].
    Ceska R; Sobra J; Toschnerová H; Traurig J
    Cas Lek Cesk; 1992 Mar; 131(4):118-20. PubMed ID: 1581939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.
    Page MM; Ekinci EI; Jones RM; Angus PW; Gow PJ; O'Brien RC
    Intern Med J; 2014 Jun; 44(6):601-4. PubMed ID: 24946816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
    Fellin R; Baggio G; Briani G; Baiocchi MR; Manzato E; Baldo G; Crepaldi G
    Atherosclerosis; 1978 Feb; 29(2):241-9. PubMed ID: 348207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Kuo PT; Kostis JB; Moreyra AE; Hayes JA
    Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
    Brown WV
    Cardiology; 1989; 76 Suppl 1():45-51; discussion 52-4. PubMed ID: 2653623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy in children and adolescents with familial hypercholesterolemia.
    Stein EA
    Prog Clin Biol Res; 1988; 255():273-80. PubMed ID: 3340641
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
    Briones ER; Steiger D; Palumbo PJ; Kottke BA
    Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Small doses of the resin Colestid in the treatment of hyperlipoproteinemia].
    Válek J; Jirkovská A; Grafnetter D
    Cas Lek Cesk; 1991 Feb; 130(6):172-6. PubMed ID: 2004412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
    Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
    Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin.
    Asami T; Uchiyama M
    Atherosclerosis; 2002 Oct; 164(2):381-2. PubMed ID: 12204812
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
    Kane JP; Malloy MJ; Ports TA; Phillips NR; Diehl JC; Havel RJ
    JAMA; 1990 Dec; 264(23):3007-12. PubMed ID: 2243428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.